Clinical Trial Update: Does RPNI Reduce Incidence of Neuroma Formation Following Sural Nerve Biopsy [NA]

View source ↗

Summary

The trial evaluates whether Regenerative Peripheral Nerve Interface (RPNI) reduces neuroma formation after sural nerve biopsy. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroma of Lower Limb

Drugs mentioned

• Regenerative Peripheral Nerve Interface (RPNI)

Snippet

Sponsor: University of British Columbia | Conditions: Neuroma of Lower Limb | NA | Status: NOT_YET_RECRUITING